365 related articles for article (PubMed ID: 38195489)
1. Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature.
Zhao S; Qiao Z; Pfeifer R; Pape HC; Mao K; Tang H; Meng B; Chen S; Liu H
Eur J Med Res; 2024 Jan; 29(1):38. PubMed ID: 38195489
[TBL] [Abstract][Full Text] [Related]
2. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.
Oguma Y; Alessio N; Aprile D; Dezawa M; Peluso G; Di Bernardo G; Galderisi U
Cell Commun Signal; 2023 Sep; 21(1):262. PubMed ID: 37770897
[TBL] [Abstract][Full Text] [Related]
4. Modulation of fracture healing by the transient accumulation of senescent cells.
Saul D; Monroe DG; Rowsey JL; Kosinsky RL; Vos SJ; Doolittle ML; Farr JN; Khosla S
Elife; 2021 Oct; 10():. PubMed ID: 34617510
[TBL] [Abstract][Full Text] [Related]
5. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
6.
Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
[TBL] [Abstract][Full Text] [Related]
7. The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs.
Bogdanova DA; Kolosova ED; Pukhalskaia TV; Levchuk KA; Demidov ON; Belotserkovskaya EV
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612842
[TBL] [Abstract][Full Text] [Related]
8. Looking for the philosopher's stone: Emerging approaches to target the hallmarks of aging in the skin.
Lemaitre JM
J Eur Acad Dermatol Venereol; 2024 Jul; 38 Suppl 4():5-14. PubMed ID: 38881451
[TBL] [Abstract][Full Text] [Related]
9. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
10. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
11. The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.
Li B; Lyu P; Tang J; Li J; Ouchi T; Fan Y; Zhao Z; Li L
J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38306619
[TBL] [Abstract][Full Text] [Related]
12. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
Suda M; Paul KH; Minamino T; Miller JD; Lerman A; Ellison-Hughes GM; Tchkonia T; Kirkland JL
Cells; 2023 May; 12(9):. PubMed ID: 37174697
[TBL] [Abstract][Full Text] [Related]
13. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
Malaquin N; Rodier F
Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3.
Tripathi U; Nchioua R; Prata LGPL; Zhu Y; Gerdes EOW; Giorgadze N; Pirtskhalava T; Parker E; Xue A; Espindola-Netto JM; Stenger S; Robbins PD; Niedernhofer LJ; Dickinson SL; Allison DB; Kirchhoff F; Sparrer KMJ; Tchkonia T; Kirkland JL
Aging (Albany NY); 2021 Sep; 13(18):21838-21854. PubMed ID: 34531331
[TBL] [Abstract][Full Text] [Related]
15. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
Niklander SE; Lambert DW; Hunter KD
Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
[TBL] [Abstract][Full Text] [Related]
16. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
17. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
[TBL] [Abstract][Full Text] [Related]
18. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
19. Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis.
Wiley CD; Sharma R; Davis SS; Lopez-Dominguez JA; Mitchell KP; Wiley S; Alimirah F; Kim DE; Payne T; Rosko A; Aimontche E; Deshpande SM; Neri F; Kuehnemann C; Demaria M; Ramanathan A; Campisi J
Cell Metab; 2021 Jun; 33(6):1124-1136.e5. PubMed ID: 33811820
[TBL] [Abstract][Full Text] [Related]
20. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
